The changes include recommendations for first line immunotherapy in patients with high PD-L1 expression, and clarification on use of targeted therapies.
With sequence data for hundreds of advanced breast cancer samples, investigators identified genetic alterations shared with — and distinct from — those in primary tumors.
A Complete Genomics-led team isolated and sequenced the genomes of 34 circulating tumor cells from a woman with metastatic breast cancer.
The ThromboSeq test detected early-stage cancer with 81 percent accuracy and late-stage cancer with 88 percent accuracy.
Hospital will partner with several other institutions in this effort to support data-driven research into pediatric cancers and structural birth defects.
The firm said it may use the loans to finance its $1.3 billion acquisition of Euroimmun Medical Laboratory Diagnostics.
The funding will help the company to grow its business, which brokers sequencing service deals through a global online system.
The companies will integrate Cambridge's TrueMethyl technology for oxidative bisulfite sequencing with NuGen's sequencing library preparation kits.
The company said it will use the funds to expand its menu of STI tests and launch its io rapid diagnostic platform into UK sexual health clinics.
The distribution deal covers the GeneStat system and associated food testing products, including an upcoming pork DNA detection assay.
ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.
WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.
Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.
In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.